HOXA9 overexpression is commonly observed in over 70% of human acute myeloid leukemia (AML) cases and ~10% of acute lymphoblastic leukemia (ALL) cases (Jambon et al., 2019). The gene discussed is HOXA9; the disease is acute myeloid leukemia.